StockWatch
·
Pharmaceuticals
AGM/EGM30 Sept 2026, 05:50 pm

ANG Lifesciences Reappoints Chetna as Independent Director for 5 Years

AI Summary

ANG Lifesciences India Limited announced the re-appointment of Ms. Chetna as an Independent Director. The shareholders approved her reappointment for a second term of five years, effective from October 12, 2026, to October 11, 2031. Ms. Chetna brings extensive experience in corporate law, securities law, SEBI compliances, financial management, accounts, and taxation. She holds an L.L.B., is a Company Secretary, and has an MBA in Finance. She is also registered in the Independent Director Databank. The company confirmed there are no relationships between Ms. Chetna and other Directors or Key Managerial Personnel, and she is not debarred from holding a director's office by any regulatory authority.

Key Highlights

  • Ms. Chetna re-appointed as Independent Director for a 5-year term.
  • Term of reappointment: October 12, 2026, to October 11, 2031.
  • Director possesses strong expertise in corporate law and finance.
  • No disclosed relationships with other directors or KMPs.
  • Director is not debarred by any regulatory authority.